|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$70,000.56 |
3.22% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$66,192.45 |
3.05% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$54,355.99 |
2.50% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$53,624.97 |
2.47% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$52,129.16 |
2.40% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$50,344.62 |
2.32% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$47,986.73 |
2.21% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$47,457.42 |
2.19% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$47,473.40 |
2.19% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$47,258.33 |
2.18% |
| Waters Corporation |
WAT |
941848103 |
120 |
$47,350.80 |
2.18% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$46,370.62 |
2.14% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$46,394.91 |
2.14% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$45,540.11 |
2.10% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$45,371.72 |
2.09% |
| Steris Plc |
STE |
G8473T100 |
169 |
$45,335.94 |
2.09% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$45,373.72 |
2.09% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$44,586.90 |
2.05% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,186.78 |
2.04% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$43,780.86 |
2.02% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$43,942.29 |
2.02% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$43,156.04 |
1.99% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$43,137.24 |
1.99% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$42,827.10 |
1.97% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$42,470.32 |
1.96% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$42,290.36 |
1.95% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$42,374.88 |
1.95% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$42,334.23 |
1.95% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$41,382.00 |
1.91% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$40,761.25 |
1.88% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$40,540.81 |
1.87% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$40,576.75 |
1.87% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$40,351.15 |
1.86% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$39,589.66 |
1.82% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$39,511.41 |
1.82% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$38,604.12 |
1.78% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$38,506.15 |
1.77% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$38,322.90 |
1.77% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$37,632.54 |
1.73% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$37,475.50 |
1.73% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$37,327.56 |
1.72% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$37,363.75 |
1.72% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$37,182.53 |
1.71% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$37,047.34 |
1.71% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$37,012.29 |
1.70% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$36,970.41 |
1.70% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$36,384.23 |
1.68% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$34,939.74 |
1.61% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$34,732.05 |
1.60% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$32,614.24 |
1.50% |
| US Dollar |
$USD |
|
2,673 |
$2,672.73 |
0.12% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|